Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: A systematic review and economic evaluation

Jayne Wilson; Martin Connock; F Song; Guiqing Yao; Anne Fry-Smith; James Raftery

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: A systematic review and economic evaluation

Jayne Wilson, Martin Connock, F Song, Guiqing Yao, Anne Fry-Smith, James Raftery

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-142
Number of pages	142
Journal	Health Technology Assessment
Volume	9
Issue number	25
Publication status	Published - 31 Jul 2005

Cite this

@article{c83f98a6b706479c8af596f72e34cf71,

title = "Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: A systematic review and economic evaluation",

author = "Jayne Wilson and Martin Connock and F Song and Guiqing Yao and Anne Fry-Smith and James Raftery",

year = "2005",

month = jul,

day = "31",

language = "English",

volume = "9",

pages = "1--142",

journal = "Health Technology Assessment",

issn = "2046-4924",

publisher = "NIHR Health Technology Assessment Programme",

number = "25",

}

TY - JOUR

T1 - Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: A systematic review and economic evaluation

AU - Wilson, Jayne

AU - Connock, Martin

AU - Song, F

AU - Yao, Guiqing

AU - Fry-Smith, Anne

AU - Raftery, James

PY - 2005/7/31

Y1 - 2005/7/31

M3 - Article

SN - 2046-4924

VL - 9

SP - 1

EP - 142

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 25

ER -